TYVASO DPI (TREPROSTINIL) — FDA Approval NDA214324 (UNITED THERAP)
TYVASO DPI (TREPROSTINIL) — FDA Approval NDA214324 (UNITED THERAP) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: TYVASO DPI; Active ingredients: TREPROSTINIL; Application number: NDA214324.
| Brand name | TYVASO DPI |
|---|---|
| Active ingredients | TREPROSTINIL |
| Application number | NDA214324 |
| Sponsor | UNITED THERAP |
| Dosage form | POWDER |
| Route | INHALATION |
| Marketing status | Prescription |
| Products in application | 5 |
| First approval date | 20220523 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →